Global Metagenomics Sequencing
Global Metagenomics Sequencing

Metagenomics Sequencing Comprehensive Study by Application (Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biofuel, Others), Technology (Sequencing, Bioinformatics), Service (Reagents & Consumables, Metagenomics Sequencing Services, Analysis & Data Interpretation Solutions, Others), Workflow (Sample Processing & Library Preparation, Sequencing, Data Processing & Analysis) Players and Region - Global Market Outlook to 2027

Metagenomics Sequencing Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Apr 2022 Edition 236 Pages 210 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Metagenomics Sequencing Market Scope
Metagenomics is the study of a microbial community's genomes as a whole. Cloning and studying genomes without cultivating organisms in the community is part of this procedure. The metagenomics technique has resulted in significant improvements in microbial ecology, evolution, and diversity, this activity is currently mostly carried out in many research labs. The expansion of the worldwide metagenomics sequencing market is mostly fuelled by reasons such as major applications of metagenomics in many industries, numerous initiatives and financing from government and corporate organizations for large-scale sequencing projects, and a decrease in sequencing costs.

The Metagenomics Sequencing market study is segmented, by Application (Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biofuel and Others) and major geographies with country level break-up.

Mergers and acquisitions, expansions, investments, new service launches, and collaborations are some of the companies' preferred market-exploration strategies. The company is contributing its share to increasing the company’s growth. The major key players like Illumina, Inc., Thermo Fisher Scientific, QIAGEN N.V., and PerkinElmer, Inc. are contributing their share to increasing the market growth.

Illumina, Inc. (United States), Thermo Fisher Scientific (United States), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (United States), Oxford Nanopore Technologies Plc. (United States), BGI Genomics Co., Ltd. (China), Eurofins Genomics (Germany), Macrogen Inc. (South Korea), Pacific Biosciences of California, Inc. (United States) and Swift Biosciences Inc. (United States) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AMA Research has segmented the market of Global Metagenomics Sequencing market by Type, Application and Region.

On the basis of geography, the market of Metagenomics Sequencing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In Jan 2021, Illumina, Inc. (US) collaborated with Helix to strengthen national surveillance infrastructure in the US to track the emergence and prevalence of novel SARS-CoV-2 strains, with support from the CDC. and In July 2021, QIAGEN N.V. (Netherlands) and Sysmex Corporation have forged a strategic agreement for the development and marketing of worldwide cancer companion diagnostics using NGS and Plasma-Safe-SeqS technology.


Market Trend
  • Availability of Cloud Computing for Data Management

Market Drivers
  • New Technology Innovation in NGS Platform
  • Increasing Awareness Regarding Genetic Disorders

Opportunities
  • Increasing Drug Manufactures In Developing Country
  • Increasing R&D Activities to Identify New Antibiotics and Enzymes Products

Restraints
  • Lack of Skilled Professionals Are Required
  • Budget Limits for End Users in Developing Nations

Challenges
  • Challenges Associated With Metagenomics NGS
  • Strict Government Regulation in Market


Key Target Audience
Industry Association, Downstream Vendors, Marketing & Consulting firms, Venture Capitalists, Government & Regulatory Bodies and Investors

Frequently Asked Questions (FAQ):

1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.

2. How big is the Metagenomics Sequencing Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2027.

Report Objectives / Segmentation Covered
By Application
  • Infectious Disease Diagnosis
  • Environmental Remediation
  • Gut Microbe Characterization
  • Biofuel
  • Others
By Technology
  • Sequencing
  • Bioinformatics

By Service
  • Reagents & Consumables
  • Metagenomics Sequencing Services
  • Analysis & Data Interpretation Solutions
  • Others

By Workflow
  • Sample Processing & Library Preparation
  • Sequencing
  • Data Processing & Analysis

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. New Technology Innovation in NGS Platform
      • 3.2.2. Increasing Awareness Regarding Genetic Disorders
    • 3.3. Market Challenges
      • 3.3.1. Challenges Associated With Metagenomics NGS
      • 3.3.2. Strict Government Regulation in Market
    • 3.4. Market Trends
      • 3.4.1. Availability of Cloud Computing for Data Management
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Metagenomics Sequencing, by Application, Technology, Service, Workflow and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Metagenomics Sequencing (Value)
      • 5.2.1. Global Metagenomics Sequencing by: Application (Value)
        • 5.2.1.1. Infectious Disease Diagnosis
        • 5.2.1.2. Environmental Remediation
        • 5.2.1.3. Gut Microbe Characterization
        • 5.2.1.4. Biofuel
        • 5.2.1.5. Others
      • 5.2.2. Global Metagenomics Sequencing by: Technology (Value)
        • 5.2.2.1. Sequencing
        • 5.2.2.2. Bioinformatics
      • 5.2.3. Global Metagenomics Sequencing by: Service (Value)
        • 5.2.3.1. Reagents & Consumables
        • 5.2.3.2. Metagenomics Sequencing Services
        • 5.2.3.3. Analysis & Data Interpretation Solutions
        • 5.2.3.4. Others
      • 5.2.4. Global Metagenomics Sequencing by: Workflow (Value)
        • 5.2.4.1. Sample Processing & Library Preparation
        • 5.2.4.2. Sequencing
        • 5.2.4.3. Data Processing & Analysis
      • 5.2.5. Global Metagenomics Sequencing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Metagenomics Sequencing (Price)
  • 6. Metagenomics Sequencing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Illumina, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. QIAGEN N.V. (Netherlands)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. PerkinElmer, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Oxford Nanopore Technologies Plc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. BGI Genomics Co., Ltd. (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Eurofins Genomics (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Macrogen Inc. (South Korea)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Pacific Biosciences of California, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Swift Biosciences Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Metagenomics Sequencing Sale, by Application, Technology, Service, Workflow and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Metagenomics Sequencing (Value)
      • 7.2.1. Global Metagenomics Sequencing by: Application (Value)
        • 7.2.1.1. Infectious Disease Diagnosis
        • 7.2.1.2. Environmental Remediation
        • 7.2.1.3. Gut Microbe Characterization
        • 7.2.1.4. Biofuel
        • 7.2.1.5. Others
      • 7.2.2. Global Metagenomics Sequencing by: Technology (Value)
        • 7.2.2.1. Sequencing
        • 7.2.2.2. Bioinformatics
      • 7.2.3. Global Metagenomics Sequencing by: Service (Value)
        • 7.2.3.1. Reagents & Consumables
        • 7.2.3.2. Metagenomics Sequencing Services
        • 7.2.3.3. Analysis & Data Interpretation Solutions
        • 7.2.3.4. Others
      • 7.2.4. Global Metagenomics Sequencing by: Workflow (Value)
        • 7.2.4.1. Sample Processing & Library Preparation
        • 7.2.4.2. Sequencing
        • 7.2.4.3. Data Processing & Analysis
      • 7.2.5. Global Metagenomics Sequencing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Metagenomics Sequencing (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Metagenomics Sequencing: by Application(USD Million)
  • Table 2. Metagenomics Sequencing Infectious Disease Diagnosis , by Region USD Million (2016-2021)
  • Table 3. Metagenomics Sequencing Environmental Remediation , by Region USD Million (2016-2021)
  • Table 4. Metagenomics Sequencing Gut Microbe Characterization , by Region USD Million (2016-2021)
  • Table 5. Metagenomics Sequencing Biofuel , by Region USD Million (2016-2021)
  • Table 6. Metagenomics Sequencing Others , by Region USD Million (2016-2021)
  • Table 7. Metagenomics Sequencing: by Technology(USD Million)
  • Table 8. Metagenomics Sequencing Sequencing , by Region USD Million (2016-2021)
  • Table 9. Metagenomics Sequencing Bioinformatics , by Region USD Million (2016-2021)
  • Table 10. Metagenomics Sequencing: by Service(USD Million)
  • Table 11. Metagenomics Sequencing Reagents & Consumables , by Region USD Million (2016-2021)
  • Table 12. Metagenomics Sequencing Metagenomics Sequencing Services , by Region USD Million (2016-2021)
  • Table 13. Metagenomics Sequencing Analysis & Data Interpretation Solutions , by Region USD Million (2016-2021)
  • Table 14. Metagenomics Sequencing Others , by Region USD Million (2016-2021)
  • Table 15. Metagenomics Sequencing: by Workflow(USD Million)
  • Table 16. Metagenomics Sequencing Sample Processing & Library Preparation , by Region USD Million (2016-2021)
  • Table 17. Metagenomics Sequencing Sequencing , by Region USD Million (2016-2021)
  • Table 18. Metagenomics Sequencing Data Processing & Analysis , by Region USD Million (2016-2021)
  • Table 19. South America Metagenomics Sequencing, by Country USD Million (2016-2021)
  • Table 20. South America Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 21. South America Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 22. South America Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 23. South America Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 24. Brazil Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 25. Brazil Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 26. Brazil Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 27. Brazil Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 28. Argentina Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 29. Argentina Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 30. Argentina Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 31. Argentina Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 32. Rest of South America Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 33. Rest of South America Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 34. Rest of South America Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 35. Rest of South America Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 36. Asia Pacific Metagenomics Sequencing, by Country USD Million (2016-2021)
  • Table 37. Asia Pacific Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 38. Asia Pacific Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 39. Asia Pacific Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 40. Asia Pacific Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 41. China Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 42. China Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 43. China Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 44. China Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 45. Japan Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 46. Japan Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 47. Japan Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 48. Japan Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 49. India Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 50. India Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 51. India Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 52. India Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 53. South Korea Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 54. South Korea Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 55. South Korea Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 56. South Korea Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 57. Taiwan Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 58. Taiwan Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 59. Taiwan Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 60. Taiwan Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 61. Australia Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 62. Australia Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 63. Australia Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 64. Australia Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 65. Rest of Asia-Pacific Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 66. Rest of Asia-Pacific Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 67. Rest of Asia-Pacific Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 68. Rest of Asia-Pacific Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 69. Europe Metagenomics Sequencing, by Country USD Million (2016-2021)
  • Table 70. Europe Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 71. Europe Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 72. Europe Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 73. Europe Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 74. Germany Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 75. Germany Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 76. Germany Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 77. Germany Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 78. France Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 79. France Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 80. France Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 81. France Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 82. Italy Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 83. Italy Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 84. Italy Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 85. Italy Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 86. United Kingdom Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 87. United Kingdom Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 88. United Kingdom Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 89. United Kingdom Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 90. Netherlands Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 91. Netherlands Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 92. Netherlands Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 93. Netherlands Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 94. Rest of Europe Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 95. Rest of Europe Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 96. Rest of Europe Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 97. Rest of Europe Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 98. MEA Metagenomics Sequencing, by Country USD Million (2016-2021)
  • Table 99. MEA Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 100. MEA Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 101. MEA Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 102. MEA Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 103. Middle East Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 104. Middle East Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 105. Middle East Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 106. Middle East Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 107. Africa Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 108. Africa Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 109. Africa Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 110. Africa Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 111. North America Metagenomics Sequencing, by Country USD Million (2016-2021)
  • Table 112. North America Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 113. North America Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 114. North America Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 115. North America Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 116. United States Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 117. United States Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 118. United States Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 119. United States Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 120. Canada Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 121. Canada Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 122. Canada Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 123. Canada Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 124. Mexico Metagenomics Sequencing, by Application USD Million (2016-2021)
  • Table 125. Mexico Metagenomics Sequencing, by Technology USD Million (2016-2021)
  • Table 126. Mexico Metagenomics Sequencing, by Service USD Million (2016-2021)
  • Table 127. Mexico Metagenomics Sequencing, by Workflow USD Million (2016-2021)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Metagenomics Sequencing: by Application(USD Million)
  • Table 139. Metagenomics Sequencing Infectious Disease Diagnosis , by Region USD Million (2022-2027)
  • Table 140. Metagenomics Sequencing Environmental Remediation , by Region USD Million (2022-2027)
  • Table 141. Metagenomics Sequencing Gut Microbe Characterization , by Region USD Million (2022-2027)
  • Table 142. Metagenomics Sequencing Biofuel , by Region USD Million (2022-2027)
  • Table 143. Metagenomics Sequencing Others , by Region USD Million (2022-2027)
  • Table 144. Metagenomics Sequencing: by Technology(USD Million)
  • Table 145. Metagenomics Sequencing Sequencing , by Region USD Million (2022-2027)
  • Table 146. Metagenomics Sequencing Bioinformatics , by Region USD Million (2022-2027)
  • Table 147. Metagenomics Sequencing: by Service(USD Million)
  • Table 148. Metagenomics Sequencing Reagents & Consumables , by Region USD Million (2022-2027)
  • Table 149. Metagenomics Sequencing Metagenomics Sequencing Services , by Region USD Million (2022-2027)
  • Table 150. Metagenomics Sequencing Analysis & Data Interpretation Solutions , by Region USD Million (2022-2027)
  • Table 151. Metagenomics Sequencing Others , by Region USD Million (2022-2027)
  • Table 152. Metagenomics Sequencing: by Workflow(USD Million)
  • Table 153. Metagenomics Sequencing Sample Processing & Library Preparation , by Region USD Million (2022-2027)
  • Table 154. Metagenomics Sequencing Sequencing , by Region USD Million (2022-2027)
  • Table 155. Metagenomics Sequencing Data Processing & Analysis , by Region USD Million (2022-2027)
  • Table 156. South America Metagenomics Sequencing, by Country USD Million (2022-2027)
  • Table 157. South America Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 158. South America Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 159. South America Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 160. South America Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 161. Brazil Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 162. Brazil Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 163. Brazil Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 164. Brazil Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 165. Argentina Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 166. Argentina Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 167. Argentina Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 168. Argentina Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 169. Rest of South America Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 170. Rest of South America Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 171. Rest of South America Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 172. Rest of South America Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 173. Asia Pacific Metagenomics Sequencing, by Country USD Million (2022-2027)
  • Table 174. Asia Pacific Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 175. Asia Pacific Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 176. Asia Pacific Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 177. Asia Pacific Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 178. China Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 179. China Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 180. China Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 181. China Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 182. Japan Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 183. Japan Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 184. Japan Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 185. Japan Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 186. India Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 187. India Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 188. India Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 189. India Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 190. South Korea Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 191. South Korea Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 192. South Korea Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 193. South Korea Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 194. Taiwan Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 195. Taiwan Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 196. Taiwan Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 197. Taiwan Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 198. Australia Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 199. Australia Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 200. Australia Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 201. Australia Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 202. Rest of Asia-Pacific Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 203. Rest of Asia-Pacific Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 204. Rest of Asia-Pacific Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 205. Rest of Asia-Pacific Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 206. Europe Metagenomics Sequencing, by Country USD Million (2022-2027)
  • Table 207. Europe Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 208. Europe Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 209. Europe Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 210. Europe Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 211. Germany Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 212. Germany Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 213. Germany Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 214. Germany Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 215. France Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 216. France Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 217. France Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 218. France Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 219. Italy Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 220. Italy Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 221. Italy Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 222. Italy Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 223. United Kingdom Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 224. United Kingdom Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 225. United Kingdom Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 226. United Kingdom Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 227. Netherlands Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 228. Netherlands Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 229. Netherlands Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 230. Netherlands Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 231. Rest of Europe Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 232. Rest of Europe Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 233. Rest of Europe Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 234. Rest of Europe Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 235. MEA Metagenomics Sequencing, by Country USD Million (2022-2027)
  • Table 236. MEA Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 237. MEA Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 238. MEA Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 239. MEA Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 240. Middle East Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 241. Middle East Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 242. Middle East Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 243. Middle East Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 244. Africa Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 245. Africa Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 246. Africa Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 247. Africa Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 248. North America Metagenomics Sequencing, by Country USD Million (2022-2027)
  • Table 249. North America Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 250. North America Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 251. North America Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 252. North America Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 253. United States Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 254. United States Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 255. United States Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 256. United States Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 257. Canada Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 258. Canada Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 259. Canada Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 260. Canada Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 261. Mexico Metagenomics Sequencing, by Application USD Million (2022-2027)
  • Table 262. Mexico Metagenomics Sequencing, by Technology USD Million (2022-2027)
  • Table 263. Mexico Metagenomics Sequencing, by Service USD Million (2022-2027)
  • Table 264. Mexico Metagenomics Sequencing, by Workflow USD Million (2022-2027)
  • Table 265. Research Programs/Design for This Report
  • Table 266. Key Data Information from Secondary Sources
  • Table 267. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Metagenomics Sequencing: by Application USD Million (2016-2021)
  • Figure 5. Global Metagenomics Sequencing: by Technology USD Million (2016-2021)
  • Figure 6. Global Metagenomics Sequencing: by Service USD Million (2016-2021)
  • Figure 7. Global Metagenomics Sequencing: by Workflow USD Million (2016-2021)
  • Figure 8. South America Metagenomics Sequencing Share (%), by Country
  • Figure 9. Asia Pacific Metagenomics Sequencing Share (%), by Country
  • Figure 10. Europe Metagenomics Sequencing Share (%), by Country
  • Figure 11. MEA Metagenomics Sequencing Share (%), by Country
  • Figure 12. North America Metagenomics Sequencing Share (%), by Country
  • Figure 13. Global Metagenomics Sequencing share by Players 2021 (%)
  • Figure 14. Global Metagenomics Sequencing share by Players (Top 3) 2021(%)
  • Figure 15. Global Metagenomics Sequencing share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Illumina, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Illumina, Inc. (United States) Revenue: by Geography 2021
  • Figure 19. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 20. Thermo Fisher Scientific (United States) Revenue: by Geography 2021
  • Figure 21. QIAGEN N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 22. QIAGEN N.V. (Netherlands) Revenue: by Geography 2021
  • Figure 23. PerkinElmer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. PerkinElmer, Inc. (United States) Revenue: by Geography 2021
  • Figure 25. Oxford Nanopore Technologies Plc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Oxford Nanopore Technologies Plc. (United States) Revenue: by Geography 2021
  • Figure 27. BGI Genomics Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 28. BGI Genomics Co., Ltd. (China) Revenue: by Geography 2021
  • Figure 29. Eurofins Genomics (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Eurofins Genomics (Germany) Revenue: by Geography 2021
  • Figure 31. Macrogen Inc. (South Korea) Revenue, Net Income and Gross profit
  • Figure 32. Macrogen Inc. (South Korea) Revenue: by Geography 2021
  • Figure 33. Pacific Biosciences of California, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Pacific Biosciences of California, Inc. (United States) Revenue: by Geography 2021
  • Figure 35. Swift Biosciences Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Swift Biosciences Inc. (United States) Revenue: by Geography 2021
  • Figure 37. Global Metagenomics Sequencing: by Application USD Million (2022-2027)
  • Figure 38. Global Metagenomics Sequencing: by Technology USD Million (2022-2027)
  • Figure 39. Global Metagenomics Sequencing: by Service USD Million (2022-2027)
  • Figure 40. Global Metagenomics Sequencing: by Workflow USD Million (2022-2027)
  • Figure 41. South America Metagenomics Sequencing Share (%), by Country
  • Figure 42. Asia Pacific Metagenomics Sequencing Share (%), by Country
  • Figure 43. Europe Metagenomics Sequencing Share (%), by Country
  • Figure 44. MEA Metagenomics Sequencing Share (%), by Country
  • Figure 45. North America Metagenomics Sequencing Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Illumina, Inc. (United States)
  • Thermo Fisher Scientific (United States)
  • QIAGEN N.V. (Netherlands)
  • PerkinElmer, Inc. (United States)
  • Oxford Nanopore Technologies Plc. (United States)
  • BGI Genomics Co., Ltd. (China)
  • Eurofins Genomics (Germany)
  • Macrogen Inc. (South Korea)
  • Pacific Biosciences of California, Inc. (United States)
  • Swift Biosciences Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation